Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer

BACKGROUND: Six months of adjuvant chemotherapy is regarded as the standard of care for patients with stage III colon cancer. However, whether longer treatment can improve prognosis has not been fully investigated. We conducted a phase III study comparing 6 and 12 months of adjuvant capecitabine che...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Clin Oncol
Main Authors: Suto, Takeshi, Ishiguro, Megumi, Hamada, Chikuma, Kunieda, Katsuyuki, Masuko, Hiroyuki, Kondo, Ken, Ishida, Hideyuki, Nishimura, Genichi, Sasaki, Kazuaki, Morita, Takayuki, Hazama, Shoichi, Maeda, Koutarou, Mishima, Hideyuki, Ike, Hideyuki, Sadahiro, Sotaro, Sugihara, Kenichi, Okajima, Masazumi, Saji, Shigetoyo, Sakamoto, Junichi, Tomita, Naohiro
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Japan 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5486458/
https://ncbi.nlm.nih.gov/pubmed/28078540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10147-016-1083-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados